Overview

Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma

Status:
Recruiting
Trial end date:
2025-10-08
Target enrollment:
Participant gender:
Summary
To study the efficacy and safety of camrelizumab combined with SOX regimen for adjuvant therapy of stage III gastric cancer
Phase:
Phase 2
Details
Lead Sponsor:
The Second Affiliated Hospital of Shandong First Medical University